Stay updated on Pembrolizumab for Cancer of Unknown Primary Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page.
Latest updates to the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no visible changes to study details or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check21 days agoChange DetectedA 'Last known status' entry was added, listing Imperial College London with the date 2023-12 and a verification status of Unknown.SummaryDifference0.4%
- Check28 days agoChange DetectedAdded Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%
- Check64 days agoChange DetectedRevision: v3.3.2 was applied to the page, replacing v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check71 days agoChange DetectedRemoved the government funding/operating status notice from the page. Core trial information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check85 days agoChange DetectedNo substantive changes detected in the core study content; updates appear to be minor formatting or copy edits. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
Stay in the know with updates to Pembrolizumab for Cancer of Unknown Primary Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page.